“showed a trend”

Our data also showed a trend toward statistical significance (p = 0.057) for a higher risk of death in elderly patients.

BRAF mutated implants showed a trend (p = 0,057) of higher overall p16 immunoreactivity though no such relation was observed for p53.

However, analysis of the published data by Fisher's Exact test ( Benner, 1999 ; Pazdur et al , 1999 ) showed a trend for increased incidence of grade 3 or 4 diarrhoea with UFT plus LV ( P =0.057), based on a safety population of 406 patients for UFT plus LV and 396 for the Mayo Clinic regimen ( Cunningham and James, 2001 ).

However, in patients with ADC, the combination only showed a trend toward improved PFS (median PFS: 11.53 vs. 8.23 months, HR = 0.641, P = 0.057) and did not lead to a significant OS benefit (median OS: 21.87 vs. 30.50 months, HR = 1.043, P = 0.865).

The latency to NREM sleep onset also showed a trend toward an increase (133.0 ± 36.8 min in mutants vs. 38.9 ± 16.3 min in controls, p = 0.057, Figure 4 B).

Body Mass Index Analyzing changes in BMI for the 81% of participants who were able to provide a photo of their body weight showed a trend Group × Time interaction, F (1,44) = 3.81, p = 0.057, η 2 = 0.080.

Prognosis Cases with MMR deficiency showed a trend of poor progression-free survival (PFS) and overall survival (OS) ( p = 0.057, 0.076) ( Figure 3 A,B).

Quantification of these injection sites showed a trend towards more CFSE positive fluorescent area in the CMT group compared to DAGs (CMTs: 13.5 × 10 3 ± 4.8 × 10 3 μm 2 versus DAGs: 3.1 × 10 3 ± 0.6 × 10 3 μm 2 ; p = 0.057) (Fig. 1 F).

GABA-currents recorded in KO UNT-oocytes showed a trend towards a decrease with respect to WT UNT-injected oocytes ( Fig. 6f , WT UNT, 100 ± 3.51%, n = 90; KO UNT, 87.21 ± 5.93%, n = 77, p = 0.057), while EC 50 and n H ( Fig. 6g ) remained similar (WT UNT, EC 50 = 93.74 ± 5.21 μM, n H = 1.16 ± 0.05, n = 13; KO UNT, EC 50 = 97.8 ± 4.30 μM, n H = 1.24 ± 0.06, n = 18).

Skeletal muscle weight loss can be observed in the DM and MICT groups ( P <0.01, P <0.01), while HIIT showed a trend towards alleviating this symptom ( P =0.057).

ICU mortality rates in patients with stroke showed a trend toward a yearly decline of − 4.1% in women (OR 0.91 [0.85–0.95], p = 0.057), but remained unchanged in men (OR 0.99 [0.94–1.03] p = 0.75, Fig. 4 ).

Compared to the control group, SMT participants improved their fall risk score ( p = 0.036), proprioception ( p = 0.015), reaction time ( p = 0.003), sit-to-stand performance ( p = 0.011) and executive functioning ( p = 0.001), while KIN participants improved their muscle strength ( p = 0.032) and vision ( p = 0.010), and showed a trend towards improved fall risk scores ( p = 0.057).

Moreover, patients in the RAMSES-01 cohort showed a trend with respect to improvement of motor function (odds ratio 1.943, p = 0.057).

In HPV-positive AJCC 8th edition N1 patients, those previously staged as N2b under AJCC 7th showed a trend toward inferior survival (74.5% vs. 86.2%, p=0.057).

Clinical results At day two following treatment, ketamine significantly improved MADRS scores (mean difference -6.5 [95% CI -10.6 to -2.5]; paired t -test, p = 0.003), TEPS-anticipatory scores (mean difference 6.8 [95% CI 2.9 to 9.5]; paired t -test, p = 0.038), TEPS-consummatory scores (mean difference 5.6 [95% CI 1.8 to 6.1]; paired t -test, p = 0.018) and showed a trend to improve SHAPS scores (mean difference -5.2 [95% CI -10.7 to 0.2]; paired t -test, p = 0.057) compared to placebo (Supplementary Fig.

Amotivation showed a trend of increasing as the students got closer to graduation (p=0.057).

Duration of allogrooming of the stimulus animal showed a trend level interaction of drug condition and sex ( F 1,91 = 3.73, p = 0.057).

Specifically, NT children with a greater P50 response amplitude showed less tactile reactivity [partial correlation: r = − 0.35, p = 0.029, 95% CI [− 0.61 − 0.12]], whereas autistic children showed a trend towards the opposite pattern, with greater P50 response amplitude related to more tactile reactivity [partial correlation: r = 0.38, p = 0.057, 95% CI [− 0.19 0.75]] (Fig. 5 a).

In PD patients with diphasic dyskinesia, ReHo values in the left mSFG showed a trend towards decrease after taking antiparkinsonian drugs ( p = 0.057, corrected) whereas, in patients without dyskinesia, ReHo values in the left mSFG showed a trend towards increase after taking antiparkinsonian drugs ( p = 0.064, corrected).

Nonetheless, they showed a trend for a higher frequency of DRB1*01:01 (0.182 vs. 0.064, p = 0.057), DQA1*01:01 (0.227 vs. 0.108, p = 0.091) and DQB1*06:04 (0.091 vs. 0.015, p = 0.055).

Follow up t‐tests showed a trend towards a difference in the minimum amount of contrast that could be detected between the two groups when the surround was present (t(204) = −2.31, p = 0.057, d = −0.27), which was non‐significant when it was absent (t(204) = −1.35 p = 0.179, d = −0.19). 3.4.

Though not statistically significant, HFD mice showed a trend of increased numbers of “lipid-laden-like” lesions ( Figure 3 A) after 6 months ( p = 0.057).

The presence of hematoma in our patients showed a trend toward poorer functional outcomes at discharge ( p = 0.057); however, this trend did not persist at the three-month follow-up. 4.5 Multimodal monitoring The use of multimodal monitoring is not a widespread practice in aSAH, probably due to the difficulties involved in its systematic placement and the correct interpretation of the different techniques, requiring close and coordinated collaboration between neurosurgery, neurology, anesthesia, intensive care unit and nursing services.

Mann-Whitney’s U-test showed that the drawing scores were significantly lower in AD patients for the images (bottom figures of Figure 1 ; Image 1, AD 2.81 ± 1.38, control 4.75 ± 0.77, p < 0.001; Image 2, AD 1.88 ± 1.09, control 3.56 ± 0.81, p < 0.001; Image 4, AD 1.69 ± 1.66, control 5.94 ± 2.77, p < 0.001) except for image 3, in which the difference showed a trend (AD 3.25 ± 2.58, control 5.19 ± 3.04, p = 0.057).

Analysis of urine lactate showed a trend towards significant difference ( P = 0.057) between sham and 30 min or 60 min of AII/R ( Fig 7 ).